Is Diversified Healthcare Trust (DHC) A Bargain Following Its Russell Index Removals?

Index removals put Diversified Healthcare Trust in focus

Diversified Healthcare Trust (DHC) was recently removed from the Russell Microcap Index, Russell 3000E Index, and their related value benchmarks. This reshuffle can influence trading by index-linked and institutional investors.

See our latest analysis for Diversified Healthcare Trust.

Despite the recent index removals, Diversified Healthcare Trust’s share price has shown strong momentum, with a 30 day share price return of 11.78% and a year to date share price return of 86.75%, alongside a 1 year total shareholder return of 149.41%.

If DHC’s sharp moves have your attention, it can be useful to see what else is moving, starting with solid balance sheet and fundamentals stocks screener (48 results)

With Diversified Healthcare Trust trading at a discount of about 6% to analyst price targets and an estimated intrinsic discount of roughly 52%, the key question is whether this signals mispricing or if the market is already factoring in future growth.

Most Popular Narrative: 6% Overvalued

The most followed narrative currently places Diversified Healthcare Trust's fair value at $8.75, slightly below the last close of $9.30, which frames the stock as modestly above that narrative view.

Active portfolio repositioning, executing non core asset sales, and focusing on higher growth senior housing and medical office/life science properties enables the company to concentrate capital on assets with sector tailwinds, strong demand for outpatient care settings, and embedded rent growth, supporting long term revenue and FFO growth.

Read the complete narrative.

Want to understand why this fair value sits where it does? The narrative leans heavily on steady revenue expansion, rising margins, and a tighter share count story. The full set of assumptions is what really matters.

Result: Fair Value of $8.75 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, investors still need to weigh risks for Diversified Healthcare Trust, including high leverage and potential pressure if asset sales or senior housing conversions do not go as planned.

Find out about the key risks to this Diversified Healthcare Trust narrative.

Another View on Diversified Healthcare Trust’s Valuation

The analyst narrative frames Diversified Healthcare Trust around a fair value of $8.75, slightly below the current $9.30 share price. Our DCF model points in a very different direction, with an estimated future cash flow value of $19.36, which implies the stock screens as materially undervalued. Which story do you think aligns more closely with the risks and assumptions?

Look into how the SWS DCF model arrives at its fair value.

Next Steps

If the mixed signals around Diversified Healthcare Trust have you unsure, take a closer look at the underlying data and move quickly to shape your own view using 2 key rewards and 1 important warning sign

Looking for more investment ideas beyond Diversified Healthcare Trust?

If Diversified Healthcare Trust has sharpened your focus, do not stop there. Broaden your watchlist with other clear, data driven ideas before the crowd catches on.

• Spot potential value opportunities early by scanning 43 high quality undervalued stocks that combine quality fundamentals with appealing pricing signals.
• Strengthen your income game by reviewing 10 dividend fortresses built around higher yielding companies focused on consistent shareholder payouts.
• Prioritise resilience by examining 74 resilient stocks with low risk scores that score well on financial stability and downside protection.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com